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Aim: The cagA and vacA profiles and their association with clinical findings show a distinct geographical distribution. In the present
study, we aimed to determine the cagA status and vacA allelic subtypes in strains isolated from a university hospital in Ankara and to
evaluate their associations with histopathological and endoscopic findings.
Materials and methods: A total of 120 H. pylori strains from stock cultures positive for the ureA gene were randomly included in the
present study. Of these strains, cagA and vacA allelic subtypes (s1a, s1b, s2, m1, m2) were examined by polymerase chain reaction.
Results: Of the 120 strains, 64 (53.3%) were cagA-positive. However, no significant relationship was found between clinical outcomes
and cagA positivity. There were 38 (33.6%) strains that had vacA m1 and 74 (65.5%) that had vacA m2 region. Overall, 75 (70.1%)
samples were classified as vacA s1a, 3 (2.8%) as vacA s1b, and 29 (27.1%) as vacA s2. There was no significant relationship between vacA
genotypes and endoscopic findings. The predominant vacA genotypes were s1am2 (35.6%) and s1am1 (33.6%), with almost the same
rates. Furthermore, cagA positivity was found to be significantly related with the vacA s1am1 genotype.
Conclusion: The cagA and vacA profiles of our study population are consistent with the Middle Eastern profile.
Key words: Helicobacter pylori, cagA, vacA

1. Introduction
Helicobacter pylori is a widespread microorganism and it has
been reported that more than half of the world’s population
is infected with the bacterium (1). The prevalence rate was
found to be 86% in Turkey (2). H. pylori colonises in the
mucus layer of the human stomach and is well accepted
as the causative agent of chronic gastritis, peptic ulcers,
mucosa associated lymphoid tissue lymphoma, and gastric
cancer (3). Several H. pylori virulence genes that play a role
in the pathogenesis of the disease have been identified.
The vacuolating cytotoxin and cytotoxin-associated
protein, encoded by vacuolating cytotoxin A (vacA) and
cytotoxin-associated gene A (cagA), respectively are
important virulence determinants of H. pylori (4,5). The
cagA is reported to be found in more than half of the H.
pylori isolates. It is known that cagA is a marker for the
cag pathogenicity island and is associated with increased
IL-8 production, nuclear factor–kB activation, mucosal
inflammation and development of peptic ulcers, atrophic
gastritis, and gastric cancer (6). The vacA gene encodes an
* Correspondence: cerenozkul@hacettepe.edu.tr
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87–93 kDa molecular weight VacA protein, which induces
cytoplasmic vacuoles in mammalian cells. Unlike the
cagA, all H. pylori strains possess the vacA gene but only
half of them can produce biologically active toxin. This
condition is mostly attributed to sequence differences in
the signal region (s1, s2) and middle region (m1, m2). Any
combinations of these allelic subtypes can be observed,
although the vacA s2m1 genotype is uncommon (5). It
has been reported that strains possessing vacA s1 and m1
genotypes are more virulent than those carrying vacA s2
and m2. Furthermore, type vacA s1a strains were reported
to show more toxin activity than vacA s1b, while type s2
has no detectable toxin activity and is mostly found to be
associated with ulcer disease (5,7,8).
It has been well accepted that the presence of cagA
and the distribution of vacA allelic subtypes demonstrate
a significant geographical variation (5). In the present
retrospective study, we aimed to determine the cagA
prevalence and vacA allelic subtype frequencies and their
association with clinical outcomes in a region of Turkey.
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2. Methods
2.1. Sample size
The subjects of this study were 120 previously untreated
patients seen at outpatient clinics of the Gastroenterology
Department of Hacettepe University between January
2000 and January 2009. A total of 120 H. pylori strains
from stock cultures, which had been isolated between
the years 2000 and 2009, were randomly included in the
present study. The endoscopic and histopathological
findings and demographical variables of the patients were
reviewed retrospectively. Only 80 of the patients’ data were
available in terms of histopathological findings. The study
was approved by the ethics committee.
2.2. Isolation of H. pylori
One antral biopsy specimen of each patient was used for
the isolation of the H. pylori. Brain Heart Infusion Agar
(Oxoid), which was supplemented with 7% horse blood
and antibiotics (vancomycin 6 g/mL, trimethoprim
2.5 g/mL) was used for the culturing process. After the
inoculation of biopsy samples, the plates were incubated
in a microaerophilic atmosphere at 37 °C (BBL GasPak
System). After the incubation period (48–72 h), colonies
of H. pylori were identified both by urease, catalase, and
oxidase test positivity and by observing characteristic
microscopical morphology by Gram staining. The stock
cultures were prepared from tryptic soy broth with 20%
glycerol and glass beads and were stored at –80 °C until
used.
2.3. PCR-based genotyping of cagA and vacA
DNA extraction was performed directly from stock
cultures. A number of glass beads were taken into 300
µL of Tris-EDTA buffer (10 mM Tris HCl and 1 mM

EDTA) and stored at –20 °C until processed. A standard
cetyltrimethylammonium bromide (CTAB) genomic
DNA isolation method was performed as previously
described (9). The sequence of the primers used in this
study is represented in Table 1.
In order to ascertain the presence of H. pylori DNA
in stock cultures, the H. pylori-specific ureA gene was
detected by polymerase chain reaction (PCR). A total
of 120 samples positive for the ureA gene were further
processed for the amplification of cagA and vacA alleles
(s1a, s1b, s2, m1, and m2).
PCR reactions were performed with 25 µL of
reaction mixture containing 2 µL of DNA template in a
thermocycler device (MJ Research, Waltham, MA, USA).
For the amplification of 411-bp fragments of the ureA gene,
HPU1 and HPU2 primers were used (10). PCR consisted
of 35 cycles of 1 min of denaturating step at 94 °C, 1 min
of annealing step at 48 °C, and 1 min of elongation step
at 72 °C, with a first cycle of 2 min at 95 °C and a final
cycle of 5 min at 72 °C. For the detection of cagA, a 348-bp
internal fragment of the gene was amplified using the F1
and B1 primers. The PCR program for cagA amplification
was: 95 °C, 5 min, 1 cycle; followed by 35 cycles of 94 °C
for 30 s (denaturation), 55 °C for 1 min (annealing), and
72 °C for 2 min (polymerisation); and 1 cycle at 72 °C for
5 min. The primers and conditions for the amplification
of vacA allelic subtypes were those used by Atherton et al.
(5). The amplified products were analysed on 2% agarose
gel, stained with ethidium bromide, and visualised under
UV light in order to determine the presence of specific
fragments of the cagA and vacA allelic subtypes. H. pylori
ATCC 43504 was used as a positive control. Each sample
was studied twice to confirm the accuracy of the results.

Table 1. PCR primers used in this study.
Target

Primer name

Sequence of the primers (5’ - 3’)

Size of PCR products

ureA

HPU1
HPU2

5’ GCCAATGGTAAATTAGTT 3’
5’ GCCAATGGTAAATTAGTT 3’

411 bp

cagA

F1
B1

5’ GATAACAGGCAAGCTTTTGAGG 3’
5’ CTGCAAAAGATTGTTTGGCAGA 3’

348 bp

m1

VA3F
VA3R

5’ GGTCAAAATGCGGTCATGG 3’
5’ CCATTGGTACCTGTAGAAAC 3’

290 bp

m2

VA4F
VA4R

5’ GGAGCCCCAGGAAACATTG 3’
5’ CATAACTAGCGCCTTGCAC 3’

352 bp

s1a

SS1F
VA1R

5’ GTCAGCATCACACCGCAAC 3’
5’ CTGCTTGAATGCGCCAAAC 3’

190 bp

s1b

SS3F
VA1R

5’ AGCGCCATACCGCAAGAG 3’
5’ CTGCTTGAATGCGCCAAAC 3’

187 bp

s2

SS2F
VA1R

5’ GCTAACACGCCAAATGATCC 3’
5’ CTGCTTGAATGCGCCAAAC 3’

199 bp
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2.4. Statistical analyses
Statistical analyses were performed with SPSS 11.0 for
Windows. In addition to the descriptive statistics, the
groups were compared using the chi-square test. In the
case of the presence of small data sets, the comparisons
between the groups were performed by Monte Carlo exact
test. P < 0.05 was considered statistically significant.
3. Results
Of the 120 H. pylori strains, 84 (70%) of them had been
isolated from children, whereas 36 (30%) of them were
from adults; the mean ages of these groups were 12.37 ±
2.94 years and 42.13 ± 18.95 years, respectively.
All of the 120 strains included in the study were positive
for the ureA gene. A total of 64 samples (53.3%) were found
to be positive for cagA. However, there was no relationship
between children and adults regarding cagA positivity (P =
0.472). Furthermore, no significant relationship was found
between endoscopic and histopathological findings and
cagA positivity (P = 0.741 and 0.554, respectively; Table 2).
Among 120 samples positive for ureA, neither vacA s nor
vacA m regions could be amplified in 5 strains. In 8 samples
the vacA s region and in 2 samples the vacA m region could

not be determined. Both vacA m1 and m2 regions were
detected together in 1 strain (0.9%). Thirty-eight (33.6%)
strains had vacA m1 and 74 (65.5%) had vacA m2 region.
Overall, 75 (70.1%) samples were classified as vacA s1a, 3
(2.8%) as vacA s1b, and 29 (27.1%) as vacA s2. There was no
significant relationship between vacA genotypes and either
endoscopic or histopathological findings.
When the results were evaluated in terms of overall
vacA genotype, it was determined that vacA s1am1,
s1am2, s1bm1, s1bm2, and s2m2 genotypes were detected
in 33.6%, 35.6%, 1.0%, 1.9%, and 27.9% of the strains,
respectively. None of the H. pylori strains were carrying
the s2m1 genotype. The distribution of vacA genotypes
according to endoscopic and histopathological findings is
represented in Table 3.
Among cagA positive strains, 86.9% had the vacA s1a
subtype, whereas only 11.5% strains had vacA s2 and 1.6%
had vacA s1b subtypes. Furthermore, it was demonstrated
that cagA positivity was significantly related with vacA
s1am1 genotype (P < 0.001). In total, 48.3% of the cagA
positive strains were classified as vacA s1am1 genotype,
and 12.1% of them were classified as vacA s2m2 genotype
(Table 4).

Table 2. The distribution of cagA according to different age groups and endoscopic and histopathological
findings.
cagA-negative
(n = 56)

cagA-positive
(n = 64)

Children (n = 84)

41 (48.8)

43 (51.2)

Adult (n = 36)

15 (4.7)

21 (58.3)

Normal mucosa (n = 8)

2 (25.0)

6 (75.0)

Gastritis (n = 70)

34 (48.6)

36 (51.4)

Gastroduodenitis (n = 23)

12 (52.2)

11 (47.8)

Esophagitis (n = 8)

3 (37.5)

5 (62.5)

Ulcer (n = 11)

5 (45.5)

6 (54.5)

Normal mucosa (n = 1)

1 (100.0)

0 (0)

Gastritis (n = 60)

27 (45.0)

33 (55.0)

Gastroduodenitis (n = 11)

6 (54.5)

5 (45.5)

Esophagitis (n = 5)

2 (40.0)

3 (60.0)

Ulcer (n = 3)

3 (100.0)

0 (0.0)

P

Age groups
0.472*

Endoscopic findings (n = 120)

0.741**

Histopathological findings (n = 80)

*: Chi-square test. **: Monte Carlo exact test
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Table 3. Relationship between vacA subtypes and endoscopic findings.
s1a/m1
n (%)

s1a/m2
n (%)

s1b/m
n (%)

s1b/m2
n (%)

s2/m2
n (%)

Total
n (%)

Normal mucosa

4 (57.1)

3 (42.9)

0 (0)

0 (0)

0 (0)

7 (100.0)

Gastritis

18 (30.5)

21 (35.6)

1 (1.7)

2 (3.4)

17 (28.8)

59 (100.0)

GD

6 (27.3)

7 (31.8)

0 (0)

0 (0)

9 (40.9)

22 (100.0)

Esophagitis

4 (66.7)

2 (33.3)

0 (0)

0 (0)

0 (0)

6 (100.0)

Ulcer

3 (30.0)

4 (40.0)

0 (0)

0 (0)

3 (30.0)

10 (100.0)

Total

35 (33.6)

37 (35.6)

1 (1.0)

2 (1.9)

29 (27.9)

104 (100.0)

Endoscopic findings

Histopathological findings
Normal mucosa

0 (0)

0 (0)

0 (0)

0 (0)

0 (0)

0 (0)

Gastritis

20 (36.4)

18 (32.7)

0 (0)

1 (1.8)

16 (29.1)

55 (100.0)

GD

3 (27.3)

6 (54.5)

0 (0)

0 (0)

2 (18.2)

11 (100.0)

Esophagitis

1 (25.0)

2 (50.0)

0 (0)

0 (0)

1 (25.0)

4 (100.0)

Ulcer

0 (0)

1 (33.3)

0 (0)

0 (0)

2 (66.7)

3 (100.0)

Total

24 (32.9)

27 (37.0)

0 (0)

1 (1.4)

21 (28.7)

73 (100.0)

GD: Gastroduodenitis.
Table 4. The relationship between cagA status and vacA genotypes.
s1a/m1
n (%)

s1a/m2
n (%)

s1b/m1
n (%)

s1b/m2
n (%)

s2/m2
n (%)

cagA (+), n (%)

28 (48.3)

22 (37.9)

1 (1.7)

0 (0)

7 (12.1)

cagA (–), n (%)

7 (15.2)

15 (32.6)

0 (0)

2 (4.4)

22 (47.8)

4. Discussion
H. pylori genotypes and the prevalence of virulent bacterial
genotypes, as well as their association with gastrointestinal
diseases, show a distinct geographical distribution (5,11).
Thus, in the present study we investigated the cagA
prevalence and vacA allelic subtypes retrospectively and
evaluated their relationships with clinical outcomes in
strains that had been isolated at Hacettepe University
Hospital. Table 5 summarises the vacA s and m genotype
rates in the present study and in other studies from Turkey
(7,12–17).
It has been known that cagA positivity rates and their
association with clinical outcomes differ from region to
region. In general, the cagA prevalence rate has been found
to be between 50% and 60% in Middle Eastern countries,
whereas in the East Asian countries almost all isolated
strains are cagA-positive (18). In Turkey, Saltık et al. (19)

P
<0.001

reported the cagA positivity rate as 55.6% in 45 isolates
and they found no significant difference between the cagA
positivity and the severity of the gastroduodenal symptoms.
Our present findings, regarding a determination of a
cagA positivity rate of 53.3% and no association between
endoscopic findings and cagA status, are similar to those
of Saltık et al. (19). In another study from Turkey, Safak et
al. reported the cagA prevalence rate as 36.3% (20). Such
an association has previously been reported, especially in
Western isolates (21). However, this relationship could not
be determined in strains isolated from Asian countries
(22,23). On the other hand, in a current study from Turkey,
Karaman et al. reported a cagA positivity rate of 65.5% and
they also found a significant relationship between cagA
status and peptic ulcer disease (17).
The different combinations of vacA s and m regions
identify the virulence characteristic of the H. pylori strains.
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Table 5. The vacA s and m genotype rates of the present study and other studies from Turkey.
Sample size
(n)

No detected
genotype*

vacA s1
n (%)

vacA s2
n (%)

vacA m1
n (%)

vacA m2
n (%)

Present study

120

16

78 (72.9)†

29 (27.1)

38 (33.6)

74 (65.5)

Saribasak et al., 2004 (7)

65

1

55 (94.8)

3 (5.2)

8 (22.2)

28 (77.8)

Aydin et al., 2004 (12)

98

0

87 (88.8)

11 (11.2)

50 (51.0)

48 (49.0)

Salih et al., 2007 (13)

21

3

20 (100.0)

0 (0)

12 (66.7)

6 (33.3)

Erzin et al., 2006 (14)

91

0

81 (89.0)

10 (11.0)

38 (41.8)

53 (58.2)

Bolek et al., 2007 (15)

44

0

41 (93.2)

3 (6.8)

24 (54.5)

20 (45.5)

Umit et al., 2008 (16)

57

2

32 (64.0)

18 (36.0)

23 (43.4)

30 (56.4)

Karaman et al., 2011 (17)

29

0

22 (75.9)

7 (24.1)

16 (55.2)

13 (44.8)

*: Either vacA s or m regions could not be determined.
†
: Both vacA s1a and s1b were established together.

It has been reported that type s1m1 strains produce a higher
cytotoxin activity in vitro than type s1m2 strains, while
s2m2 strains, which are considered as less virulent strains,
produce no detectable cytotoxin. Thus, identification of
the vacA profiles of the isolated strains and evaluation
of these subtype combinations together with the clinical
outcome of the patients is of significant importance.
In accordance with the previous reports from Turkey,
we found vacA s1a as the predominant vacA s subtype with
a rate of 70.1% (7,13,24). According to the reports from
East Asian countries, all H. pylori strains isolated from
East Asian countries are vacA s1 and cagA-positive, where
the gastric cancer incidence has been reported in higher
rates (25). This finding supports the idea that the strains
with vacA s1 genotypes secrete the toxin more effectively
from the cell and strains with both vacA s1 and cagA cause
more serious gastrointestinal symptoms (8). Moreover,
most of the vacA s1 strains are also cagA-positive (26).
In the present study we found that 52 of the 59 cagApositive strains were carrying the vacA s1 type, consistent
with the literature. There was no association between the
vacA s1 genotype and endoscopic findings. Our results are
consistent with other reports from Turkey (7,12). However,
in their study, Erzin et al. (14) reported an association
between vacA s1a positive strains and duodenal ulcer and
gastric cancer.
The association between the vacA m region and
clinical outcome is still unclear. Such an association was
reported in a few studies from Eastern and Middle Eastern
countries (27). Salehi et al. (28) reported the vacA m1
and m2 rates as 40% and 60%, respectively, in an Iranian
population. They also found an association between vacA
m1 genotype and gastroduodenal pathology. We found the
vacA m2 genotype as predominant with a rate of 65.5%.
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Our findings are in contrast with the results of Erzin
et al. (14) and Aydin et al. (12), who reported the vacA
m1 and m2 genotypes with an almost equal presence.
However, Saribasak et al. (7) reported the predominant
vacA m subtype as m2 (77.8%) and found no association
between vacA m genotypes and the development of peptic
ulcer. According to our present results, the vacA profile of
Turkey is similar with those of Middle Eastern countries,
where the vacA s1 and m2 subtypes have been reported to
be predominant subtypes in many studies (28,29).
According to the results of the large metaanalysis
study by Sugimoto et al. (30), in the combination of vacA
s and m region genotypes, the predominant genotype was
found to be vacA s1m2 (44.8%) in the North Middle East
considering data from Turkey, Iran, and Iraq. In the same
study, the overall rates of vacA s1m1, s2m1, and s2m2 were
reported as 34.0%, 1.7%, and 19.5%, respectively. However,
no previous studies had examined the subtypes of vacA s1
from these countries. In the study from Turkey by Erzin
et al. (14), the vacA s1 subtypes were also examined,
and they reported the vacA s1am2 as predominant.
Consistently with the data from Middle East countries and
from Turkey, we found the predominant vacA genotype as
s1am2 (35.6%). However, the frequencies of vacA s1am1
and s1am2 were almost same, with the rates of 33.6% and
35.6%, respectively. Moreover, we found the rate of vacA
s2m2, the less virulent type, as 27.9%. None of the strains
were carrying the vacA s2m1 genotype, consistent with the
literature (5).
According to the previous reports from Asian
countries, the predominant strains were reported to be
vacA s1cm1 and s1cm2 (11,31). The vacA s1c subtype was
first identified by Van Doorn et al. (32) in strains isolated
from East Asian countries. Since there were no reports
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from Turkey and Middle Eastern countries regarding the
presence of the vacA s1c subtype, it was not investigated in
the present study.
The relationship between the presence of cagA and the
vacA s1 region was first described by Atherton et al. (5).
In a recent study from Turkey, Nagiyev et al. (33) reported
an association between more virulent vacA genotypes and
cagA positivity. In the present study, as well, we found that
48.3% of the cagA-positive strains were carrying the more
virulent vacA s1am1 genotype, whereas only 12.1% of those
had the less virulent vacA s2m2 genotype. Thus, the vacA
s1am1 genotype was found to be significantly associated
with the presence of cagA. Moreover, among 28 patients
harbouring more virulent cagA+ / vacA s1am1 isolates, 26 of
them were in the gastritis, gastroduodenitis, or esophagitis
group, indicating that the genotype vacA s1m1 and its
association with the cagA positivity increase the risk of
developing more severe gastric lesions. Such an association
was also demonstrated by Andreson et al. (34) from Estonia,
who reported the predominant genotype as vacA s1am1
and indicated a significant association of cagA positivity
with vacA s1am1 and s1am2. In Turkey this association
was reported by Karaman et al. (17). They found that all 16
strains with the s1m1 genotype were also cagA-positive.
In contrast with the studies reporting the association of
clinical outcomes with H. pylori virulence genes, especially
with cagA status, we did not show such an association of
endoscopic findings with either cagA or vacA gene status.

Interestingly, this is in agreement with the majority of
other reports from Turkey, in which cagA prevalence rates
were also found between 55% and 69% (17,19). Moreover,
although the majority of the isolated H. pylori strains are
cagA-positive in Asian countries, associations of cagA
status and disease outcome are not encountered in this
region (35). This association was also not demonstrated in
studies conducted on Iranian populations (36,37).
In the present study, we aimed to determine the cagA
prevalence, vacA subtypes, and their associations with
clinical findings in Turkey. To the best of our knowledge,
there are limited reports from this region regarding the
cagA and vacA status of Turkey. This study may contribute
to the regional findings, since the geographical data in this
issue are of significant importance.
In conclusion, we determined the cagA prevalence
rate as 53.3% and the vacA predominant subtype as
s1am2. However, no association was determined between
clinical outcomes and virulence genotypes. A significant
association between cagA positivity and vacA s1am1
genotype was found, in accordance with the previous
reports in the literature.
In the light of the present results, it can be said that the
data from Turkey are consistent with the Middle Eastern
profile regarding cagA positivity, vacA status, and their
associations with clinical outcomes. Further studies with
larger sample sizes are needed in order to clarify the cagA
and vacA profile of Turkey.
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